Event

Gina Eagle

MD
Insmed Incorporated

Naoki Hasegawa

MD, PhD
Keio University Hospital;Keio University School of Medicine;Keio Universtity School of Medicine

Rachel M. Thomson

MBBS, PhD, FRACP
GREENSLOPES PRIVATE HOPSPITAL;Greenslopes Private Hospital;University of Queensland, Gallipoli Medical Research Centre

Stephen J. Ruoss

MD
Stanford University;Stanford University School of Medicine

Michael R. Loebinger

MD, PhD
Royal Brompton Hospital, and Imperial College

Timothy R. Aksamit

MD
Mayo Clinic

Kevin Winthrop

MD, MPH
OHSU Division of Infectious Diseases;OHSU School of Medicine;OHSU-PSU School of Public Health;Oregon Health & Science University;Oregon Health and Science University;Oregon Health and Sciences Uni

Jae Joon. Yim

MD
Seoul National University College of Medicine

Felix C. Ringshausen

MD
Hannover Medical School and German Center for Lung Research (DZL)

Theodore K. Marras

MD
Toronto Western Hospital and University of Toronto;University of Toronto;University of Toronto and Toronto Western Hospital;University of Toronto and Toronto Western Hospital, University Health Networ

Stephen K. Field

MD
Cumming School of Medicine, University of Calgary

Doreen J. Addrizzo-Harris

MD
New York Univ Med Ctr;New York University School of Medicine;NYU

David E. Griffith

MD
Univ of Texas Hlth Ctr At Tyler;University of Texas at Tyler;University of Texas Health Science Center;University of Texas Health Science Center at Tyler

Jim Nezamis

PhD
Insmed Incorporated

Kozo Morimoto

MD
Fukujuji Hospital, Japan Anti-Tuberculosis Association;Japan Anti-Tuberculosis Association Fukujuji Hospital

Patrick A. Flume

MD
Med Univ of S Carolina;Medical University of South Carolina

Luigi R. Codecasa

MD
TB Reference Centre, Villa Marelli Institute/Niguarda Hospital

Anne E. O'Donnell

MD
Georgetown University Hospital

Lucy Morgan

MBBS
Concord Hospital

Adam T. Hill

MD
Royal Infirmary and University of Edinburgh

Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)